A selective norepinephrine reuptake inhibitor that takes 4 to 6 weeks to reach full effect
GLP-1 activation begins at this level, producing mild appetite changes in most researchers
This unique mechanism is one reason why it has attracted significant attention in obesity medicine research
High-dose potassium supplements can be dangerous, especially for people with kidney disease or those taking certain medications like ACE inhibitors or potassium-sparing diuretics
It's not an emergency care system
Meta-analyses of these and other studies have demonstrated: Reductions in total cholesterol typically in the range of 15% from baseline, varying by agent and population Decreases in LDL cholesterol ranging from 17%, generally more modest than dedicated lipid-lowering therapies Reductions in triglycerides of 515%, with greater effects often seen in those with higher baseline levels Variable effects on HDL cholesterol , with small increases (1-2%) or neutral effects reported The magnitude of lipid improvements appears to correlate with the degree of weight loss achieved, suggesting that metabolic benefits may be partially mediated through adiposity reduction
